Child, F., Ortiz‐Romero, P., Alvarez, R., Bagot, M., Stadler, R., Weichenthal, M., Alves, R., Quaglino, P., Beylot‐Barry, M., Cowan, R., Geskin, L., Pérez‐Ferriols, A., Hellemans, P., Elsayed, Y., Phelps, C., Forslund, A., Kamida, M., & Zinzani, P. (2016). phase II multicentre trial of oral quisinostat, a histone deacetylase inhibitor, in patients with previously treated stage IB–IVA mycosis fungoides/Sézary syndrome3. British journal of dermatology, 175, 80–88. http://access.bl.uk/ark:/81055/vdc_100035003937.0x00002f